ALIN - Trademark Details
Status: 700 - Registered
Serial Number
86148901
Registration Number
4824753
Word Mark
ALIN
Status
700 - Registered
Status Date
2015-10-06
Filing Date
2013-12-19
Registration Number
4824753
Registration Date
2015-10-06
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2015-07-21
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
HUDSON, TAMARA BREE
Statements
Goods and Services
Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, endocrinology for treatment of adrenal failure, thyroiditis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely rheumatology for treatment of rheumatoid arthritis, gout, post-traumatic arthritis, osteoarthritis, synovitis, bursitis, epicondylitis, ankylosing spondylitis, systemic or discoid lupus erythematosus, dermatomyositis, scleroderma, other collagen diseases, other osteoarticular diseases which require chronic corticosteroid administration; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory; immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely dermatology for treatment of pemphigus, erythema multiforme, exfoliative dermatitis, psoriasis, contact dermatitis, keloid lesions, hyperthrophic lichen planus, alopecia areata, urticaria, eczema, rosacea; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, allergology for treatment of bronchial asthma, urticaria, drug or food allergy, hypersensitivity reactions, allergic rhinitis, allergic sinusitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely otolaryngology for treatment of vasomotor rhinitis, other types of rhinitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, ophthalmology for treatment of allergic, acute or chronic conjunctivitis; scleritis, uveitis/iridocyclitis, optic neuritis, corneal infections, keratitis, marginal ulcers, throphic disorders, conjunctival/corneal physical/chemical burning, inflammatory reactions; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, gastroenterology for treatment of ulcerative colitis, regional enteritis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, pulmonology for treatment of bronchoaspiration, Löeffler syndrome, sarcoidosis, interstitial pulmonary fibrosis, chronic bronchitis, emphysema; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely hematology for treatment of autoimmune anemias or thrombocytopenias, leukemias, lymphomas, intravascular coagulation syndrome; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, oncology for treatment of nausea/vomiting associated with cancer chemotherapy prevention; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, miscellaneous for treatment of shock syndromes, cerebral edema
Translation of Words in Mark
The wording ALIN has no meaning in a foreign language.
Translation of Words in Mark
The English translation of the word "ALIN" in the mark is "LOWEST".
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2014-01-07
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
JENNIFER A. VAN KIRK
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
Mexico | False |
Trademark Events
Event Date | Event Description |
2013-12-23 | NEW APPLICATION ENTERED IN TRAM |
2014-01-07 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2014-03-26 | ASSIGNED TO EXAMINER |
2014-04-01 | NON-FINAL ACTION WRITTEN |
2014-04-01 | NON-FINAL ACTION E-MAILED |
2014-04-01 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2014-04-01 | NON-FINAL ACTION WRITTEN |
2014-04-01 | NON-FINAL ACTION E-MAILED |
2014-04-01 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2014-06-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2014-06-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-06-05 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-06-27 | ASSIGNED TO EXAMINER |
2014-08-13 | EXAMINERS AMENDMENT -WRITTEN |
2014-08-13 | EXAMINERS AMENDMENT E-MAILED |
2014-08-13 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2014-08-13 | EXAMINER'S AMENDMENT ENTERED |
2014-08-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2014-08-21 | ASSIGNED TO LIE |
2014-08-22 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2014-09-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2014-09-30 | PUBLISHED FOR OPPOSITION |
2014-09-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2014-11-25 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2015-05-22 | TEAS PETITION TO AMEND BASIS RECEIVED |
2015-05-22 | TEAS EXTENSION RECEIVED |
2015-05-29 | ASSIGNED TO PETITION STAFF |
2015-05-22 | EXTENSION 1 FILED |
2015-06-01 | EXTENSION 1 GRANTED |
2015-06-02 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2015-06-03 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
2015-06-03 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
2015-06-15 | NOTICE OF ALLOWANCE CANCELLED |
2015-06-15 | 1(B) BASIS DELETED; NEW BASIS REQUESTED |
2015-07-01 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-07-21 | PUBLISHED FOR OPPOSITION |
2015-07-21 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-10-06 | REGISTERED-PRINCIPAL REGISTER |
2020-10-06 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |